Hepatology Resource Center
Liver distress: Top 10 care and cost concerns
December 01, 2016This slide show highlights the top 10 issues we covered this year on managing treatment of patients with HCV infection.
HCV patients on DAAs need hepatitis B testing November 03, 2016By Mark L. FuerstA test for hepatitis B virus should be done for patients beginning treatment with direct-acting antiviral therapy for their hepatitis C, experts advise. DAA therapies can reduce overall HCV treatment costs November 03, 2016By Mark L. FuerstA new study shows all-oral direct-actin antiviral agents for hepatitis C can provide both short- and long-term economic value. HCV patient cost sharing for DAAs does not make sense October 03, 2016By Mark L. FuerstInsurance arrangements for direct-acting antivirals, where hepatitis C virus patients share the burden of treatment costs, are ineffective says one researcher. Path to eradicate HCV goes through people who inject drugs October 03, 2016By Mark L. FuerstTargeting people who inject drugs may be the pathway to eradication of the hepatitis C virus (HCV), according to a recent review. Study confirms sofosbuvir-ribavirin works against HCV genotype 2 September 12, 2016By Mark L. FuerstA real-world study confirms the effectiveness and safety of the all-oral combination of sofosbuvir plus ribavirin for treatment of hepatitis C virus GT2 infection. Alcohol use high among hepatitis C virus patients September 12, 2016By Mark L. FuerstU.S. study finds those with HCV three times more likely to drink five or more drinks per day every day vs. those without HCV infections. HCV core antigen tests a less costly diagnostic option July 29, 2016By Mark L. FuerstHCVcAg tests may cost less and improve diagnostic capacity in settings of high hepatitis C virus prevalence, according to new research. Financial, insurance issues hinder HCV treatment study says July 29, 2016By Mark L. FuerstRemoving potential barriers to treat hepatitis C virus is yet another key component to patient access, notes lead researcher. Baby boomers face higher mortality from HCV infections July 07, 2016By Mark L. FuerstLead researcher says economic impact of hepatitis C virus will increase unless action is taken now.